TGR5 Could Be a Therapeutic Target for MG

According to Myasthenia Gravis News, researchers recently determined a new therapeutic target for myasthenia gravis (MG): activating a bile acid receptor called TGR5. By activating this bile acid receptor, researchers…

Continue Reading TGR5 Could Be a Therapeutic Target for MG